NCT00591396View on ClinicalTrials.gov

A Phase I Trial of ZIO-101 in Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Solid Tumors
Interventions
DRUG

ZIO-101 (Darinaparsin)

Dose Escalation of ZIO-101 (Darinaparsin) given daily for five consecutive days to be repeated every 28 days for up to six months

Trial Locations (1)

Unknown

Houston

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY